Cardiology Grand Rounds Guest Speaker Series

Touchscreen Summary: 

Heart Failure Precision Medicine: Old Tricks and New Treats

David Lanfear, MD, MS, is Head of the Advanced Heart Failure and Cardiac Transplant Section at the Henry Ford Heart and Vascular Institute in Detroit, MI, where he is also Director of the Advanced Heart Failure fellowship program, Research Scientist in the Center for Health Services Research, and Associate Professor of Medicine at Wayne State University.

Date: 
January 29, 2016 - 12:00pm - 1:00pm
Event Location: 
Sarver Heart Center
Event Location Other: 
Room 4137

TOPIC:  Heart Failure Precision Medicine: Old Tricks and New Treats

David Lanfear, MD, MS, is Head of the Advanced Heart Failure and Cardiac Transplant Section at the Henry Ford Heart and Vascular Institute in Detroit, MI, where he is also Director of the Advanced Heart Failure fellowship program, Research Scientist in the Center for Health Services Research, and Associate Professor of Medicine at Wayne State University.  Dr. Lanfear earned his medical degree from the University of Michigan Medical School, with residency and fellowship at Barnes-Jewish Hospital/Washington University in St. Louis, and is board certified in Cardiovascular Disease and Advanced Heart Failure and Transplant Cardiology.  Dr. Lanfear is an active researcher with multiple NIH funded projects focused on genomics and heart failure.  His main project is funded by an R01 from NHLBI titled "Impact of Race and Genetic Factors on Beta Blocker Effectiveness in Heart Failure”.  He has 82 published manuscripts, most either as first or senior author, and having reached high-impact journals including JAMA, JACC, and Circulation:Heart Failure. Dr. Lanfear is very involved in academic societies such having served on the ACC Heart Failure/Tx leadership council, and serving currently on the AHA Functional Genomics and Translation Biology Leadership committee, chair ACC Mechanical Circulatory working group, Chair ACC Young Investigators Award Committee, and he was recently appointed to the HFSA Executive Council.